About the Authors
- Béatrice Cambien
-
* E-mail: cambien@unice.fr
Affiliations Université de Nice Sophia Antipolis, UFR Médecine, Nice, France, INSERM UMR 576, Nice, France
- Peggy Richard-Fiardo
-
Affiliations Université de Nice Sophia Antipolis, UFR Médecine, Nice, France, INSERM UMR 576, Nice, France
- Babou F. Karimdjee
-
Affiliations Université de Nice Sophia Antipolis, UFR Médecine, Nice, France, INSERM UMR 576, Nice, France, Clinique St Jean, Cagnes sur mer, France
- Violette Martini
-
Affiliations Université de Nice Sophia Antipolis, UFR Médecine, Nice, France, INSERM UMR 576, Nice, France
- Bernard Ferrua
-
Affiliation INSERM U895, Nice, France
- Bruno Pitard
-
Affiliations INSERM U915, Nantes, France, In-Cell-Art, Nantes, France
- Heidy Schmid-Antomarchi
-
Affiliations Université de Nice Sophia Antipolis, UFR Médecine, Nice, France, INSERM UMR 576, Nice, France
- Annie Schmid-Alliana
-
Affiliations Université de Nice Sophia Antipolis, UFR Médecine, Nice, France, INSERM UMR 576, Nice, France
Competing Interests
Bruno Pitard owns stock in In-Cell-Art Co., which develops 704 for vaccine applications. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: BC. Performed the experiments: BC PR-F BFK VM BF. Analyzed the data: BC BP. Contributed reagents/materials/analysis tools: BP HS-A A-SA. Wrote the paper: BC.